<?xml version='1.0' encoding='utf-8'?>
<document id="25312593"><sentence text="Understanding adverse drug reactions in older adults through drug-drug interactions." /><sentence text="The aims of this study are to evaluate prevalence and characteristics of adverse drug reactions (ADRs) and to evaluate the potential contribution of specific medications, therapeutic categories and drug-drug interactions (DDIs) in older adults" /><sentence text="" /><sentence text="All ADR reporting forms of persons aged 65+ years collected by the pharmacovigilance of one of the main hospitals in Italy during 2013 were evaluated" /><sentence text=" DDIs were analysed by a computerized prescription system (INTERCheck) and based on the interactions' database managed by the Istituto di Ricerche Farmacologiche Mario Negri" /><sentence text=" DDIs were classified according to their clinical relevance as contraindicated, major, and moderate" /><sentence text="" /><sentence text="Amongst all the ADR reporting forms (n=1014) collected during 2013, 343 affected older adults" /><sentence text=" The most frequent ADRs were: haemorrhages (n=122, 35" /><sentence text="5%), allergic reactions (n=56, 16" /><sentence text="3%), and elevated International Normalized Ratio (INR&gt;6, n=54, 15" /><sentence text="7%)" /><sentence text=" The specific medications that contributed to ADRs were warfarin (42" /><sentence text="5%), acenocumarol (9%), and allopurinol (8"><entity charOffset="5-17" id="DDI-PubMed.25312593.s14.e0" text="acenocumarol" /><entity charOffset="28-39" id="DDI-PubMed.25312593.s14.e1" text="allopurinol" /><pair ddi="false" e1="DDI-PubMed.25312593.s14.e0" e2="DDI-PubMed.25312593.s14.e0" /><pair ddi="false" e1="DDI-PubMed.25312593.s14.e0" e2="DDI-PubMed.25312593.s14.e1" /></sentence><sentence text="5%); while the therapeutic categories were haematological agents (67%) and proton pump inhibitors (13%)" /><sentence text=" A total of 912 DDIs were found; one third of them were contraindicated or major and 31" /><sentence text="5% of them potentially contributed to ADRs; of these, the most frequent were: warfarin and heparin (contraindicated, n=5); warfarin and a statin (major, n=38); warfarin and a proton pump inhibitor (moderate, n=40)" /><sentence text=" At least one DDI contributed to 66 haemorrhages out of 122 (54%) and to 41 elevated INR out of 54 (76%)" /><sentence text="" /><sentence text="DDIs significantly contribute to the onset of ADRs in older adults and intervention programmes, e" /><sentence text="g" /><sentence text=", the employment of a computerized system, may reduce the burden of iatrogenic illnesses in the elderly" /><sentence text="" /></document>